- Report
- June 2024
- 200 Pages
Global
From €7535EUR$7,950USD£6,295GBP
- Report
- May 2024
- 136 Pages
Global
From €6160EUR$6,499USD£5,146GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1185EUR$1,250USD£990GBP
Palmoplantar Keratoderma (PPK) is a group of skin disorders characterized by thickening of the palms and soles of the feet. It is a rare condition, but can be treated with a variety of dermatological drugs. These drugs are typically topical creams, ointments, and lotions that contain active ingredients such as salicylic acid, urea, and lactic acid. These ingredients help to reduce the thickness of the skin and improve its appearance. In addition, some drugs may also contain corticosteroids to reduce inflammation and itching.
The Palmoplantar Keratoderma Drug market is a niche market, with a limited number of companies offering products for this condition. Some of the companies in this market include Galderma, Leo Pharma, and Stiefel Laboratories. These companies offer a variety of products, ranging from topical creams to oral medications. Additionally, some of these companies also offer products specifically designed for PPK, such as the Galderma Cetaphil Restoraderm line. Show Less Read more